Carcinogenesis, Vol 19, 2121-2128, Copyright © 1998 by Oxford University Press
JG Scharf, W Schmidt-Sandte, SA Pahernik, G Ramadori, T Braulke and H Hartmann
The insulin-like growth factors (IGF-I and -II) are structurally related
peptides participating in the regulation of metabolism, growth and cellular
differentiation. In the present study, the human hepatoma cell line PLC was
studied for the expression of individual components of the IGF axis.
Northern blot analysis using IGF-I and -II coding cDNAs failed to detect
IGF-I- or -II-specific transcripts in total RNA from PLC cells.
Biosynthesis of type I and II IGF receptors was demonstrated by northern
blotting and binding studies as well as cross- linking of the respective
radiolabeled ligand. Both IGF-I and -II stimulated [3H]-thymidine
incorporation dose-dependently. The mitogenic activity of exogenously added
IGFs was reduced by the presence of IGF- binding proteins of 24, 30, 34, 41
and 45 kDa in supernatants of PLC cells identified as IGFBP-4, -1, -2 and
-3, respectively, by [125I]IGF- I ligand-, immuno- and northern blotting.
Biosynthesis of IGFBP-3 was stimulated dose-dependently by IGF-I and -II,
while IGFBP-1, -2 and -4 were not affected. The increase of IGFBP-3 in
response to IGF-I and -II was due to a stimulation of IGFBP-3 specific mRNA
as well as to an inhibition of IGFBP-3 endocytosis. Proteolytic activity
for rhIGFBP-3 was detected in media from PLC cells at acidic pH that was
inhibited by the aspartyl protease inhibitor pepstatin A as well as after
immunodepletion of cathepsin D from media of PLC cells. Thus, a role of
cathepsin D for the regulation of IGFBP-3 bioavailability via endocytosis
in acidic prelysosomal compartments was suggested. The susceptibility of
PLC for IGF-I and -II was restricted by their ability to increase the
abundance of inhibitory IGFBPs and to decrease the level of IGF-I receptor
expression. The present data point to the IGF axis as a complex regulatory
system that self limits the mitogenic activity of exogenous IGFs.
ARTICLES
Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)
Department of Medicine, George-August-Universitat, Gottingen, Germany. jscharf@med.uni-goettingen.de
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Cheng, C.-J. Tseng, T. T.C. Lin, I. Cheng, H.-W. Pan, H.-C. Hsu, and Y.-M. Lee Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway Carcinogenesis, July 1, 2008; 29(7): 1319 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Lee, C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y.-H. P. Lee, S. G. Kim, and K. W. Kang Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells Mol. Pharmacol., October 1, 2007; 72(4): 1082 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Scharf, F. Dombrowski, R. Novosyadlyy, C. Eisenbach, I. Demori, B. Kubler, and T. Braulke Insulin-Like Growth Factor (IGF)-Binding Protein-1 Is Highly Induced during Acute Carbon Tetrachloride Liver Injury and Potentiates the IGF-I-Stimulated Activation of Rat Hepatic Stellate Cells Endocrinology, July 1, 2004; 145(7): 3463 - 3472. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh, P. K. H. Chow, L. L. P. Ooi, and K.-C. Soo A Possible Role for Insulin-like Growth Factor-binding Protein-3 Autocrine/Paracrine Loops in Controlling Hepatocellular Carcinoma Cell Proliferation Cell Growth Differ., March 1, 2002; 13(3): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shalamanova, B. Kubler, J.-G. Scharf, and T. Braulke MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6 Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1221 - E1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-G Scharf, F Dombrowski, and G Ramadori The IGF axis and hepatocarcinogenesis Mol. Pathol., June 1, 2001; 54(3): 138 - 144. [Abstract] [Full Text] |
||||
![]() |
R Issa, E Williams, N Trim, T Kendall, M J P Arthur, J Reichen, R C Benyon, and J P Iredale Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors Gut, April 1, 2001; 48(4): 548 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text] |
||||







